Previous 10 | Next 10 |
Incyte (Nasdaq: INCY) today announced that several abstracts featuring data from its oncology portfolio will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held May 31 – June 4 in Chicago, and at the European Hematology Association 2024 (EHA20...
2024-05-13 08:04:18 ET More on Incyte Incyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade) Incyte Non-GAAP EPS of $0.64 misses by $0.19, revenue of $880.89M misses by $43.75M Incyte Q1 2024 Earnings Preview Read the full article on Seeking Alpha ...
Incyte commences Dutch Auction tender offer to repurchase up to $1.67 billion of outstanding common shares Incyte Corporation (Nasdaq:INCY) (the “Company”) today announced that its Board of Directors approved a share repurchase authorization of $2.0 billion. The Compan...
2024-05-09 06:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We live in the best of times where life is not capped at 45 or 50 years of age, all thanks to wonderful discoveries in the field of biotechnology. The resources being invested to produce new dr...
2024-05-02 04:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-30 22:00:03 ET Evan David Seigerman from BMO Capital issued a price target of $52.00 for INCY on 2024-04-30 16:29:00. The adjusted price target was set to $52.00. At the time of the announcement, INCY was trading at $52.05. The overall price target consensus is a...
2024-04-30 21:15:01 ET BMO Capital analyst issues MARKET PERFORM recommendation for INCY on April 30, 2024 04:29PM ET. The previous analyst recommendation was Market Perform. INCY was trading at $52.05 at issue of the analyst recommendation. The overall analyst consensus...
2024-04-30 11:43:02 ET Incyte Corporation (INCY) Q1 2024 Earnings Conference Call April 30, 2024 8:00 AM ET Company Participants Ben Strain - Associate VP, IR Hervé Hoppenot - CEO Christiana Stamoulis - CFO Pablo Cagnoni - President, Head of Research &am...
2024-04-30 07:03:19 ET More on Incyte Incyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade) Incyte: A Potential GARP Superstar Incyte Corporation (INCY) Q4 2023 Earnings Call Transcript Incyte Q1 2024 Earnings Preview Incyte to acquire immune-focu...
LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 11:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 06:15:05 ET BMO Capital analyst issues UNDERPERFORM recommendation for INCY on July 2, 2024 04:26AM ET. The previous analyst recommendation was Market Perform. INCY was trading at $60.87 at issue of the analyst recommendation. The overall analyst consensus : B...